Aureus Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.41M Sell
9,841
-9,325
-49% -$2.17M 0.16% 67
2025
Q4
$3.97M Buy
19,166
+1,487
+8% +$294K 0.25% 54
2025
Q3
$3.28M Sell
17,679
-1,434
-8% -$246K 0.21% 59
2025
Q2
$2.92M Sell
19,113
-4,822
-20% -$741K 0.19% 64
2025
Q1
$3.97M Sell
23,935
-530
-2% -$82.9K 0.28% 57
2024
Q4
$3.54M Buy
24,465
+168
+0.7% +$26K 0.23% 59
2024
Q3
$3.94M Sell
24,297
-2,894
-11% -$461K 0.26% 59
2024
Q2
$3.97M Sell
27,191
-2,491
-8% -$370K 0.28% 55
2024
Q1
$4.7M Sell
29,682
-1,791
-6% -$285K 0.32% 53
2023
Q4
$4.93M Sell
31,473
-6,151
-16% -$943K 0.36% 44
2023
Q3
$5.86M Buy
37,624
+855
+2% +$141K 0.47% 41
2023
Q2
$6.09M Sell
36,769
-9,017
-20% -$1.46M 0.46% 40
2023
Q1
$7.1M Buy
45,786
+540
+1% +$87.2K 0.56% 35
2022
Q4
$7.99M Buy
45,246
+222
+0.5% +$38.3K 0.69% 31
2022
Q3
$7.36M Sell
45,024
-2,046
-4% -$346K 0.64% 34
2022
Q2
$8.36M Buy
47,070
+6,787
+17% +$1.21M 0.67% 34
2022
Q1
$7.14M Sell
40,283
-3,831
-9% -$652K 0.47% 37
2021
Q4
$7.55M Sell
44,114
-5,697
-11% -$933K 0.47% 36
2021
Q3
$8.04M Buy
49,811
+739
+2% +$126K 0.53% 35
2021
Q2
$8.08M Buy
49,072
+20,489
+72% +$3.39M 0.52% 38
2021
Q1
$4.7M Buy
28,583
+3,491
+14% +$565K 0.36% 41
2020
Q4
$3.95M Sell
25,092
-1,769
-7% -$261K 0.33% 41
2020
Q3
$4M Sell
26,861
-66
-0.2% -$9.77K 0.38% 40
2020
Q2
$3.79M Buy
26,927
+897
+3% +$131K 0.41% 38
2020
Q1
$3.41M Buy
26,030
+5,036
+24% +$714K 0.47% 37
2019
Q4
$3.06M Sell
20,994
-1,665
-7% -$226K 0.34% 44
2019
Q3
$2.93M Sell
22,659
-532
-2% -$70.1K 0.36% 43
2019
Q2
$3.23M Sell
23,191
-3,539
-13% -$490K 0.4% 42
2019
Q1
$3.74M Sell
26,730
-504
-2% -$67.5K 0.5% 38
2018
Q4
$3.51M Sell
27,234
-1,393
-5% -$194K 0.55% 40
2018
Q3
$3.96M Sell
28,627
-836
-3% -$111K 0.5% 39
2018
Q2
$3.58M Sell
29,463
-1,102
-4% -$137K 0.49% 41
2018
Q1
$3.92M Sell
30,565
-303
-1% -$41K 0.59% 39
2017
Q4
$4.31M Buy
30,868
+536
+2% +$74.7K 0.67% 38
2017
Q3
$3.94M Buy
30,332
+5,171
+21% +$685K 0.62% 40
2017
Q2
$3.33M Buy
25,161
+1,876
+8% +$239K 0.56% 43
2017
Q1
$2.87M Sell
23,285
-589
-2% -$70.4K 0.5% 44
2016
Q4
$2.75M Sell
23,874
-4,119
-15% -$476K 0.54% 43
2016
Q3
$3.31M Buy
27,993
+2,688
+11% +$326K 0.66% 42
2016
Q2
$3.07M Sell
25,305
-999
-4% -$114K 0.66% 41
2016
Q1
$2.85M Sell
26,304
-226
-0.9% -$23.4K 0.62% 38
2015
Q4
$2.73M Sell
26,530
-4,339
-14% -$436K 0.61% 39
2015
Q3
$2.88M Sell
30,869
-1,790
-5% -$173K 0.72% 38
2015
Q2
$3.18M Sell
32,659
-10,405
-24% -$1.04M 0.67% 44
2015
Q1
$4.33M Sell
43,064
-913
-2% -$92.8K 1% 41
2014
Q4
$4.6M Sell
43,977
-216
-0.5% -$22.8K 1.12% 40
2014
Q3
$4.71M Buy
44,193
+5,120
+13% +$531K 1.18% 40
2014
Q2
$4.09M Buy
39,073
+9,650
+33% +$975K 1.02% 41
2014
Q1
$2.89M Buy
29,423
+1,039
+4% +$96.3K 0.74% 45
2013
Q4
$2.6M Sell
28,384
-740
-3% -$68.2K 0.7% 45
2013
Q3
$2.52M Sell
29,124
-550
-2% -$49.3K 0.86% 46
2013
Q2
$2.55M Buy
+29,674
New +$2.52M 0.91% 46

Other funds holding JNJ

Aureus Asset Management's JNJ Position: Q1 2026 in Review

Aureus Asset Management reduced its Johnson & Johnson (JNJ) stake by 49% in Q1 2026, selling an estimated $2.17M and leaving 9,841 shares worth $2.41M. The position accounts for 0.16% of the portfolio, ranked #67.

Aureus Asset Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.36M in Q2 2022. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aureus Asset Management held 9,841 shares of Johnson & Johnson worth $2.41M as of Q1 2026.
  • Aureus Asset Management sold 9,325 Johnson & Johnson shares in Q1 2026, an estimated $2.17M.
  • Johnson & Johnson made up 0.16% of Aureus Asset Management's portfolio in Q1 2026, its #67 holding.
  • Aureus Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Aureus Asset Management's Johnson & Johnson position peaked at $8.36M in Q2 2022.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aureus Asset Management's 13F filing for Q1 2026, filed 13 May 2026.